Rafferty Asset Management
TBIO

Rafferty Asset Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Rafferty Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-994
Closed -$32K – 1273
2022
Q2 		$32K Sell
994
-259
-21% -$17.9K ﹤0.01% 1116
2022
Q1 		$121K Buy
+1,253
New +$190K ﹤0.01% 1165

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Rafferty Asset Management's TBIO Position: Q3 2022 in Review

Rafferty Asset Management sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2022, closing a stake of 994 shares — an estimated $32K sold.

Rafferty Asset Management first reported a position in TBIO in Q1 2022 and held it in 2 quarters. The position peaked at $121K in Q1 2022. 32 funds tracked by Wall St. Rank hold TBIO as of Q3 2022.

  • Rafferty Asset Management reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 994 Telesis Bio, Inc. Common Stock shares in Q3 2022, an estimated $32K.
  • Rafferty Asset Management first reported a position in Telesis Bio, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Rafferty Asset Management's Telesis Bio, Inc. Common Stock position peaked at $121K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2022.

Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.